When restricting analysis to the seven studies examing E-cadherin in ESCC, however, the result remained unchanged, with an HR of 1.12 (95% CI, 1.05-1.19), again, with significant heterogeneity. This evidence concerns the gene CDH1 and esophageal squamous cell carcinoma.